Cover Image
市場調查報告書

寵物動物用醫藥品:2017年

Animal Pharm Medicines for Companion Animals 2017

出版商 Animal Pharm 商品編碼 594573
出版日期 內容資訊 英文 77 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
寵物動物用醫藥品:2017年 Animal Pharm Medicines for Companion Animals 2017
出版日期: 2017年12月07日 內容資訊: 英文 77 Pages
簡介

本報告提供寵物動物用醫藥品市場相關調查,現在、未來市場趨勢,活躍的醫藥品企業,寵物用醫藥品的法規,疼痛治療、管理的方法,及一般疾病治療等相關詳細分析。

摘要整理

簡介

  • 動物健康產業
  • 寵物市場
  • 摘要

第2章 在寵物中活躍的醫藥品企業

  • ZOETIS
  • BOEHRINGER INGELHEIM (+ MERIAL)
  • MERCK/MSD ANIMAL HEALTH
  • ELANCO
  • BAYER ANIMAL HEALTH
  • VIRBAC
  • VETOQUINOL
  • DECHRA PHARMACEUTICALS
  • ARATANA THERAPEUTICS
  • 日本全藥工業

第3章 寵物醫藥品的法規

  • 美國、EU的法規當局
  • 法規指導
  • 寵物醫藥品的可用性
  • 無認證醫藥品的使用
  • 其他地區概要

第4章 疼痛的治療和管理

  • 疼痛的評估
  • 疼痛治療藥
  • 現在開發中的動物用產品

第5章 寵物的癌症治療

  • 癌症治療的評估
  • 現在可利用的癌症治療藥
  • 癌症治療藥的未來趨勢

第6章 過敏性皮膚疾病

  • 過敏性皮膚疾病的評估
  • 過敏性皮膚疾病治療藥

第7章 心血管疾病

  • 心血管疾病的評估
  • 心臟治療藥
  • 心血管治療藥的未來趨勢

第8章 抗菌劑:困境

  • 抗菌劑的利用及抵抗力的發展
  • 抗菌劑的未來趨勢

第9章 摘要

目錄
Product Code: 87556

This unique report will help companies develop strategies to meet the growing needs of the companion animal sector. The global veterinary drugs market is expected to exhibit a 5.1% compound annual growth rate from 2016-2024. The fastest growth is expected to be in the companion animal sector in economies including the US, BRazil, China and Russia.

The global trend of rising pet ownership increases the demand for pharmaceutical innovations in this sector. This report focuses on two of the world's most popular pets - cats and dogs.

Key insights include:

  • Current and future market trends
  • Active pharmaceutical companies
  • Regulation of companion animal medicine
  • Approaches to pain treatment and management
  • Treatment of common disorders

Table of Contents

Contents

Executive Summary

Introduction

  • 1.1. The Animal Health Industry
  • 1.2. The Companion Animal Sector
    • 1.2.1. Changes in Pet Ownership
    • 1.2.2. The Future of Companion Animal Health in Developed Markets
    • 1.2.3. The Future of Companion Animal Health in Emerging Markets
  • 1.3. Summary

Chapter 2: The Pharmaceutical Companies Active in Companion Animals

  • 2.1. ZOETIS
  • 2.2. BOEHRINGER INGELHEIM (+ MERIAL)
  • 2.3. MERCK/MSD ANIMAL HEALTH
  • 2.4. ELANCO
  • 2.5. BAYER ANIMAL HEALTH
  • 2.6. VIRBAC
  • 2.7. VETOQUINOL
  • 2.8. DECHRA PHARMACEUTICALS
  • 2.9. ARATANA THERAPEUTICS
  • 2.10. NIPPON ZENYAKU KOGYO

Chapter 3: Regulation of Companion Animal Medicines

  • 3.1. The United States (US) and European (EU) Regulatory Authorities
  • 3.2. Regulatory Guidance
  • 3.3. Availability of Companion Animal Medicines
  • 3.4. Use of Unlicensed Medicinal Products
  • 3.5. Overview of Other Regions
    • 3.5.1. BRAZIL
    • 3.5.2. RUSSIA
    • 3.5.3. INDIA
    • 3.5.4. CHINA

Chapter 4: Treatment and Management of Pain

  • 4.1. Evaluating Pain
    • 4.1.1. Future Trends in Assessing Pains
  • 4.2. Pain Therapeutics
    • 4.2.1. Opioids
      • 4.2.1.1. Future Trends for Opiods:
    • 4.2.2. Non-steroidal anti-inflammatory drugs
      • 4.2.2.1. Future trends for NSAIDs
    • 4.2.3. Local anaesthetics
    • 4.2.4. Other analgesics with currently approved veterinary products
    • 4.2.5. Other analgesics without currently approved veterinary products
  • 4.3. Products currently in development for veterinary application

Chapter 5: Treatment of Pet Cancer

  • 5.1. Assessing Cancer Therapies
  • 5.2. Currently Available Cancer Treatments
  • 5.3. Future Trends for Cancer therapy

Chapter 6: Allergic Skin Disorders

  • 6.1. Evaluating Allergic Skin Disease
  • 6.2. Allergic Dermatitis Therapeutics
    • 6.2.1. ACUTE DISEASE FLARES
    • 6.2.2. CHRONIC DISEASE
    • 6.2.3. THE PRODUCTS
    • 6.3. Future trends and products currently in development for the treatment of allergic skin disease.

Chapter 7: Cardiac Disorders

  • 7.1. Assessing Cardiovascular Disease
  • 7.2. Cardiology Therapeutics
    • 7.2.1. Diuretics
    • 7.2.2. Spironolactone
    • 7.2.3. ACE Inhibitors
    • 7.2.4. Pimobendan
    • 7.2.5. Calcium Channel Blockers
    • 7.2.6. Methylxanthines
  • 7.3. Future Trends for Cardiovascular Drugs

Chapter 8: Antimicrobials: A Dilemma

  • 8.1. Antimicrobial use and the Development of Resistance
    • 8.1.1. Antimicrobial prescribing habits and use in companion animal veterinary medicine
  • 8.2. Future trends for antimicrobials

Chapter 9: Summary

References

List of Figures

  • Figure 1: Estimated human equivalent ages for older pets
  • Figure 2: Prevalence of hip dysplasia in a selection of breeds, reproduced from King, 2017.(Data from Orthopedic Foundation for Animals.)
  • Figure 3: Colorado State University canine pain scale
  • Figure 4: An excerpt of the FMPI reproduced from Gruen et al., 2015
  • Figure 5: Voyce Pro dog collar
  • Figure 6: Canine osteosarcoma, reproduced from Biller et al., 2016
  • Figure 7: Image of dog with lymphoma, notice enlarged lymph nodes under jaw
  • Figure 8: Canine Atopic Dermatitis, reproduced from Olivry et al., 2010
  • Figure 9: The CADESI-03 Scale, reproduced from Olivry et al., 2007
  • Figure 10: PVAS, reproduced from Olivry et al., 2007
  • Figure 11: The CADLI, reproduced from Plant et al., 2012
  • Figure 12: Body regions assessed by the SCORFAD Scale, reproduced from Steffan et al., 2012
  • Figure 13: How heart disease affects different body functions
  • Figure 14: Radiographic image of heart enlargement
  • Figure 15: Canine electrocardiography
  • Figure 16: Canine echocardiography

List of Tables

  • Table 1: Number of dogs and cats in the Top 20 pet owning countries
  • Table 2: Companion Animal therapeutic area guidelines issued by the EMA and FDA CVM
  • Table 3: Multifactorial CMIs for chronic pain assessment in veterinary medicine
  • Table 4: Common locations of pet cancers
  • Table 5: Tabs vs mAbs
  • Table 6: Frequency of use of different antimicrobials
  • Table 7: The antibiotics mentioned and frequency with which they were mentioned for the top five indications where antibiotics are said to be prescribed for use in cats
  • Table 8: The antibiotics mentioned and frequency with which they were mentioned for the top five indications where antibiotics are said to be prescribed for use in dogs
Back to Top